MoviPrep Interactions
There are 421 drugs known to interact with MoviPrep (polyethylene glycol 3350 with electrolytes), along with 7 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 36 are major, 383 are moderate, and 2 are minor.
- View all 421 medications that may interact with MoviPrep
- View MoviPrep alcohol/food interactions (1)
- View MoviPrep disease interactions (7)
Most frequently checked interactions
View interaction reports for MoviPrep (polyethylene glycol 3350 with electrolytes) and the medicines listed below.
- amitriptyline
- amlodipine
- amoxicillin
- aspirin
- atorvastatin
- clonazepam
- diazepam
- doxycycline
- fexofenadine
- folic acid
- furosemide
- gabapentin
- ibuprofen
- lactulose
- levothyroxine
- melatonin
- metformin
- mirtazapine
- omeprazole
- ondansetron
- oxycodone
- pantoprazole
- Paracetamol (acetaminophen)
- prednisone
- propranolol
- quetiapine
- tamsulosin
- venlafaxine
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
MoviPrep alcohol/food interactions
There is 1 alcohol/food interaction with MoviPrep (polyethylene glycol 3350 with electrolytes).
MoviPrep disease interactions
There are 7 disease interactions with MoviPrep (polyethylene glycol 3350 with electrolytes) which include:
- inflammatory bowel disease
- intestinal obstruction disorders
- GI obstruction/perforation
- arrhythmias
- impaired gag reflex
- renal disease
- seizures
Report options
More about MoviPrep (polyethylene glycol 3350 with electrolytes)
- MoviPrep consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (407)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: laxatives
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.